16 January 2020
: Case report
Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast: An Uncommon Finding in an Uncommon Patient
Unknown etiology
Alessandra Surace1E*, Viola Liberale2F, Marta D’Alonzo2D, Silvia Pecchio2B, Maria Grazia Baù1G, Nicoletta Biglia2ADOI: 10.12659/AJCR.919856
Am J Case Rep 2020; 21:e919856
Abstract
BACKGROUND: Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign breast lesion.
CASE REPORT: PASH is reported in a young female in treatment for neurological diseases with multi-drug therapy (clonazepam, valproate and risperidone). Her menstrual cycles are irregular, and she reached menarche very late.
CONCLUSIONS: The higher PASH prevalence in premenopausal woman (the majority of whom are actively taking oral contraceptive pills), in 24% to 47% of men with gynecomastia and during pregnancy supports a hormonal etiology; the interaction between clonazepam, valproate, risperidone and progesterone could increase the level of progesterone that could stimulate PASH growth.
Keywords: Breast Diseases, Breast Neoplasms, Drug Therapy, Combination, Mastectomy, Segmental, Angiomatosis, Biopsy, Large-Core Needle, Breast, Drug Interactions, Hyperplasia, Progesterone, Stromal Cells
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947344
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946589
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947316
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947693
Most Viewed Current Articles
21 Jun 2024 : Case report
100,250
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,680
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,071
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
24,897
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200